MENU
+Compare
XGN
Stock ticker: NASDAQ
AS OF
Jul 21, 04:59 PM (EDT)
Price
$6.94
Change
-$0.06 (-0.86%)
Capitalization
27.06M

XGN Exagen Forecast, Technical & Fundamental Analysis

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases... Show more

XGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for XGN with price predictions
Jul 18, 2025

XGN sees MACD Histogram crosses below signal line

XGN saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on June 12, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 39 instances where the indicator turned negative. In of the 39 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on XGN as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XGN broke above its upper Bollinger Band on July 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for XGN entered a downward trend on July 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where XGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XGN advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.192) is normal, around the industry mean (24.694). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.528) is also within normal values, averaging (43.458).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
XGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

XGN is expected to report earnings to fall 25.15% to -14 cents per share on July 29

Exagen XGN Stock Earnings Reports
Q2'25
Est.
$-0.15
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.18
The last earnings report on May 05 showed earnings per share of -20 cents, beating the estimate of -21 cents. With 87.37K shares outstanding, the current market capitalization sits at 27.06M.
A.I. Advisor
published General Information

General Information

a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
1261 Liberty Way
Phone
+1 760 560-1501
Employees
179
Web
https://www.exagen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XYZ72.822.09
+2.95%
Block Inc
BRSL14.430.02
+0.14%
Brightstar Lottery
MATV7.25-0.06
-0.82%
Mativ Holdings
FBLG0.67-0.02
-2.70%
FibroBiologics
OPAD2.14-0.09
-4.04%
Offerpad Solutions

XGN and Stocks

Correlation & Price change

A.I.dvisor tells us that XGN and MXCT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XGN and MXCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XGN
1D Price
Change %
XGN100%
-2.51%
MXCT - XGN
26%
Poorly correlated
-6.05%
RDNT - XGN
25%
Poorly correlated
-2.29%
MASS - XGN
23%
Poorly correlated
-1.18%
MYO - XGN
23%
Poorly correlated
-2.93%
QDEL - XGN
23%
Poorly correlated
-4.61%
More